ESTROGENIC SUBSTANCE Drug Patent Profile
✉ Email this page to a colleague
When do Estrogenic Substance patents expire, and when can generic versions of Estrogenic Substance launch?
Estrogenic Substance is a drug marketed by Wyeth Ayerst and is included in one NDA.
The generic ingredient in ESTROGENIC SUBSTANCE is estrone. There are nine drug master file entries for this compound. Additional details are available on the estrone profile page.
Summary for ESTROGENIC SUBSTANCE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 106 |
Patent Applications: | 3,822 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ESTROGENIC SUBSTANCE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ESTROGENIC SUBSTANCE
US Patents and Regulatory Information for ESTROGENIC SUBSTANCE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Ayerst | ESTROGENIC SUBSTANCE | estrone | INJECTABLE;INJECTION | 083488-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |